Medical & Imaging Labs

Industry Profile Report

Dive Deep into the industry with a 25+ page industry report (pdf format) including the following chapters

Industry Overview Current Conditions, Industry Structure, How Firms Operate, Industry Trends, Credit Underwriting & Risks, and Industry Forecast.

Call Preparation Call Prep Questions, Industry Terms, and Weblinks.

Financial Insights Working Capital, Capital Financing, Business Valuation, and Financial Benchmarks.

Industry Profile Excerpts

Industry Overview

The 7,200 medical and imaging labs in the US perform analytical and diagnostic services for patients and health care providers. Medical labs provide a variety of testing services, including routine clinical, anatomic pathology, genetic, and esoteric tests. Other types of testing include drug use, risk assessment for life insurance, and dental. Imaging labs provide diagnostic procedures, including x-rays; MRI, CT and PET scans; ultrasound; mammography; nuclear medicine; and fluoroscopy.

Competition from Health Care Providers and Academia

Medical and imaging labs compete with hospitals, clinics, physicians, and universities for services.

Complying With Government Regulation

Medical and imaging labs must be licensed and must adhere to federal and state government regulations which establish technical, operational, personnel and quality requirements.

Industry size & Structure

A typical medical lab operates out of single location, employs 63 workers, and generates about $11 million annually. A typical imaging lab operates out of a single location, employs about 17 workers, and generates about $4.5 million annually.

    • The medical lab industry consists of about 7,200 companies, employs 320,000 workers, and generates about $72 billion annually.
    • Large medical labs include Laboratory Corporation of America, Quest Diagnostics, and Sonic Healthcare. Large imaging labs include RadNet, Imaging Healthcare Specialists, and Intrinsic Imaging.
                                  Industry Forecast
                                  Medical & Imaging Labs Industry Growth
                                  Source: Vertical IQ and Inforum

                                  Recent Developments

                                  May 18, 2024 - Prices Unchanged
                                  • Medical and imaging labs kept prices unchanged during the first quarter of 2024, according to the US Bureau of Labor Statistics (BLS). Medical and imaging laboratory industry employment increased slightly during the fourth quarter of 2024 while wages for nonsupervisory employees were unchanged, according to the BLS.
                                  • The Food and Drug Administration (FDA) has finalized a plan to regulate laboratory-developed medical tests due to concerns about reliability and risks to patients. The agency says that inaccurate results may force patients to unnecessarily start a new treatment or delay care. Major industry players, including academic medical centers that develop their own tests and large commercial laboratories, have opposed the plan, and some analysts expect the opponents to sue the FDA to prevent the new rules from going into effect.
                                  • The US Department of Justice, the Federal Trade Commission, and the US Department of Health and Human Services said in early March that they are investigating how certain transactions in the healthcare sector may increase consolidation and boost corporate profits at the expense of patient health, worker safety, quality of care, and affordability. The agencies have issued a request for information, seeking public comment on deals conducted by health systems, private payers, private equity funds, and other alternative asset managers that involve healthcare providers, facilities, or ancillary products or services. Research shows the competition in healthcare provider and payer markets leads to higher-quality and lower-cost healthcare, as well as greater access to care and higher wages and benefits for workers, agency officials said.
                                  • North American healthcare sector private equity (PE) deal values totaled about $29 billion in 2023, according to Bain & Company. Activity in provider businesses have historically comprised a large share of US deals but PE interest in related industries such as medical and imaging labs has increased. Biopharma accounted for 25% of deal activity and 54% of deal value in 2023. North America retained its position as the region with the highest value of healthcare deals.
                                  Get A Demo

                                  Vertical IQ’s Industry Intelligence Platform

                                  See for yourself why over 60,000 users trust Vertical IQ for their industry research and call preparation needs. Our easy-to-digest industry insights save call preparation time and help differentiate you from the competition.

                                  Build valuable, lasting relationships by having smarter conversations -
                                  check out Vertical IQ today.

                                  Request A Demo